Monoclonal Anti-alpha-synuclein Antibodies For Preventing Tau Aggregation


The invention relates to a novel use of monoclonal anti-alpha-synuclein antibodies. The antibodies can be used to prevent tau aggregation and thereby treating tauopathies such as Alzheimer's disease.

Family Member PDF
Family Member Preview
These are the images from a related family member, as the full document isn't yet available to us from the patent office.
Document History
  • Publication: Jun 28, 2018
  • Application: Dec 21, 2017
    WO EP 2017083994 W
  • Priority: Jan 5, 2017
    DK DK PA201700016 A
  • Priority: Dec 22, 2016
    DK DK PA201600782 A

Download Citation

Sign in to the Lens